Sign in to confirm you’re not a bot
This helps protect our community. Learn more
Comments are turned off. Learn more
Duane Boise & MMJ - DEA delays cannabis research
0Likes
46Views
2022Aug 7
MMJ International holdings, the premier medical research company, who filed Investigational New Drug (IND) applications with the FDA was pleased to learn at a congressional hearing aired on C-SPAN on Wednesday, that federal regulators recognized that valuable research into marijuana is needed. For decades researchers have been inhibited by cannabis's current legal status. The FDA, DEA and NIDA described how they are taking steps to resolve the issue.

Follow along using the transcript.